-
1Academic Journal
Authors: D. Yu. Grebenkin, A. V. Ryabova, A. M. Kuramshina, I. V. Kislyakov, E. D. Zhukova, Д. Ю. Гребенкин, А. В. Рябова, А. М. Курамшина, И. В. Кисляков, Е. Д. Жукова
Source: Drug development & registration; Том 12, № 1 (2023); 131-141 ; Разработка и регистрация лекарственных средств; Том 12, № 1 (2023); 131-141 ; 2658-5049 ; 2305-2066
Subject Terms: таблетки, dissolution profile studies, uniformity of dosage, tablets, ТСКР, однородность дозирования
File Description: application/pdf
Relation: https://www.pharmjournal.ru/jour/article/view/1444/1101; https://www.pharmjournal.ru/jour/article/downloadSuppFile/1444/1563; Tastemur Y., Gumus E., Ergul M., Ulu M., Akkaya R., Öztürk A., Taskiran A. S. Positive effects of angiotensin-converting enzyme (ACE) inhibitor, captopril, on pentylenetetrazole-induced epileptic seizures in mice. Tropical Journal of Pharmaceutical Research. 2020;19(3):637–643. DOI:10.4314/tjpr.v19i3.26.; Jin L., Liu C., Zhang N., Zhang R., Yan M., Bhunia A., Zhang Q., Liu M., Han J., Siebert H.-C. Attenuation of Human Lysozyme Amyloid Fibrillation by ACE Inhibitor Captopril: A Combined Spectroscopy, Microscopy, Cytotoxicity, and Docking Study. Biomacromolecules. 2021;22(5):1910–1920. DOI:10.1021/acs.biomac.0c01802.; Alcaide-Hidalgo J. M., Margalef M., Bravo F. I, Muguerza B., López-Huertas E. Virgin olive oil (unfiltered) extract contains peptides and possesses ACE inhibitory and antihypertensive activity. Clinical Nutrition. 2020;39(4):1242–1249. DOI:10.1016/j.clnu.2019.05.016.; Nizardo N. M., Ashilah G., Budianto E. In vitro efficiency and dissolution test from captopril microencapsulation by variating composition in polyblend poly (D-lactic acid) and polycaprolactone. AIP Conference Proceedings. 2020;2242(1). DOI:10.1063/5.0008192.; Moffat A. C., Osselton M. D., Winddop B., Watts J. Clarke’s Analysis of Drugs and Poison. Chromatographia. 2011;74(7–8):649–650. DOI:10.1007/s10337-011-2100-9.; Gadad A. P., Reddy A. D., Dandagi P. M., Masthiholimath V. S. Design and characterization of hollow/porous floating beads of Captopril for pulsatile drug delivery. Asian Journal of Pharmaceutical. 2012;6(2):137–143. DOI:10.4103/0973-8398.102938.; Kumar K. M., Anil B. Biopharmaceutical disposition classification system: an extension of the bio pharmaceutical classification system. International Research Journal of Pharmacy. 2012;3(3):5–10.; Yasir M., Asif M., Kumar A., Aggarval A. Biopharmaceutical classification system. International Journal of PharmaTech Research. 2010;2(3):1681–1690.; Karakosta T. D., Tzanavaras P. D., Zacharis C. K. Development and Validation of an Automated Zone Fluidics-Based Sensor for In Vitro Dissolution Studies of Captopril Using Total Error Concept. Molecules. 2021;26(4):824. DOI:10.3390/molecules26040824.; Kapoor D., Maheshwari R., Verma K., Sharma S., Pethe A., Tekade R. K. Fundamentals of diffusion and dissolution: dissolution testing of pharmaceuticals. Drug Delivery Systems. 2020;1–45. DOI:10.1016/B978-0-12-814487-9.00001-6.; Klein S. Advancements in Dissolution Testing of Oral and Non-oral Formulations. AAPS PharmSciTech. 2019;20(7):266. DOI:10.1208/s12249-019-1479-8.; Charalabidis A., Sfouni M., Bergström C., Macheras P. The Biopharmaceutics Classification System (BCS) and the Biopharmaceutics Drug Disposition Classification System (BDDCS): Beyond guidelines. International Journal of Pharmaceutics. 2019;566:264–281. DOI:10.1016/j.ijpharm.2019.05.041.; Butler J., Hens B., Vertzoni M., Brouwers J., Berben P., Dressman J., Andreas C. J., Schaefer K. J., Mann J., McAllister M., Jamei M., Kostewicz E., Kesisoglou F., Langguth P., Minekus M., Müllertz A., Schilderink R., Koziolek M., Jedamzik P., Weitschies W., Reppas C., Augustijns P. In vitro models for the prediction of in vivo performance of oral dosage forms: Recent progress from partnership through the IMI OrBiTo collaboration. European Journal of Pharmaceutics and Biopharmaceutics. 2019;136:70–83. DOI:10.1016/j.ejpb.2018.12.010.; Zaborenko N., Shi Z., Corredor C. C., Smith-Goettler B. M., Zhang L., Hermans A., Neu C. M., Alam Md A., Cohen M. J., Lu X., Xiong L., Zacour B. M. First-Principles and Empirical Approaches to Predicting In Vitro Dissolution for Pharmaceutical Formulation and Process Development and for Product Release Testing. The AAPS journal. 2018;21(3):32. DOI:10.1208/s12248-019-0297-y.; Butler J. M., Hens B., Vertzoni M., Brouwers J. Simulated Biological Fluids with Possible Application in Dissolution Testing. Dissolution Technologies. 2011;18(3):15–18. DOI:10.14227/DT180311P15.; Egorova S. N., Pavlova A. I., Khafizova G. F., Khayatov A. R., Vorobyova N. V. On the need for introducing the pharmaceutical-technological test "Uniformity of mass of subdivided tablets" in the State Pharmacopeia of Russia. JOURNAL OF SIBERIAN MEDICAL SCIENCES. 2020;2:20–29. (In Russ.) DOI:10.31549/2542-1174-2020-2-20-29.; https://www.pharmjournal.ru/jour/article/view/1444
-
2Academic Journal
Authors: Чмелевская, Н., Илларионова, Е.
Subject Terms: ЦИННАРИЗИН, АНАЛИТИЧЕСКИЙ КОНТРОЛЬ, ОДНОРОДНОСТЬ ДОЗИРОВАНИЯ, СПЕКТРОФОТОМЕТРИЯ, ВНЕШНИЙ ОБРАЗЕЦ СРАВНЕНИЯ, КОЭФФИЦИЕНТ ПЕРЕСЧЕТА, ДИХРОМАТ КАЛИЯ, CINNARIZINЕ
File Description: text/html
-
3Academic Journal
Source: Сибирский медицинский журнал (Иркутск).
File Description: text/html
